Global Aurora Kinase B Market - Industry Analysis Size Share Growth Trends and Forecast 2022 - 2030

Global Aurora Kinase B Market - Industry Analysis Size Share Growth Trends and Forecast 2022 - 2030

  • SKU :
    SAC2059153
  • Published Date :
    June 1, 2022
  • Number of Pages :
    350.0

Product Description

The Aurora Kinase B market was valued at US$ xx in 2021, prior to COVID-19. Whereas post-COVID-19 scenario,  the market for Aurora Kinase B is projected to grow from US$ xx million in 2021, and is projected to reach xx by 2030, at a CAGR of xx% during the forecast period. Projected and forecast revenue values are in constant U.S. dollars, unadjusted for inflation. Product values are estimated based on manufacturers' revenue.

The report offers detailed coverage of Aurora Kinase B industry and main market trends. The market research includes historical and forecast market data, demand, application details, price trends, and company shares of the leading Aurora Kinase B by geography. The report splits the market size, by volume and value, on the basis of application type and geography.

In addition to this data, the report provides insight into drivers of market demand and strategies of suppliers. Key players are profiled, and their market shares in the global Aurora Kinase B market are discussed.

The market is segmented by types: 
    AZD-2811
    CS-2164
    Danusertib
    Ilorasertib
    NMI-900
    Others

It can be also divided by applications:
    Anaplastic Large Cell Lymphoma
    Kidney Cancer
    Lung Cancer
    Prostate Cancer
    Others

And this report covers the historical situation, present status and the future prospects of the global Aurora Kinase B market for 2021-2030. In this report, we analyze global market from 5 geographies: Asia-Pacific, Europe, North America, Middle East & Africa, South America.

Finally, the report provides detailed profile and data information analysis of leading company.
    AbbVie Inc
    Advenchen Laboratories LLC
    Aeterna Zentaris Inc
    Amgen Inc
    AstraZeneca Plc
    Chipscreen Biosciences Ltd
    Cielo Therapeutics Inc
    Sanofi
    Sareum Holdings Plc

Report Includes:
- xx data tables and xx additional tables
- An overview of global Aurora Kinase B market
- An detailed key players analysis across regions
- Analyses of global market trends, with historical data, estimates for 2022 and projections of compound annual growth rates (CAGRs) through 2030
- Insights into regulatory and environmental developments
- Information on the supply and demand scenario and evaluation of technological and investment opportunities in the Aurora Kinase B market
- Profiles of major players in the industry, including     AbbVie Inc,     Advenchen Laboratories LLC,     Aeterna Zentaris Inc,     Amgen Inc,     AstraZeneca Plc.....

Research objectives
    To study and analyze the global Aurora Kinase B consumption (value & volume) by key regions/countries, product type and application, history data from 2018 to 2021, and Forecast to 2030.
    To understand the structure of Aurora Kinase B market by identifying its various subsegments.
    Focuses on the key global Aurora Kinase B manufacturers, to define, describe and analyze the sales volume, value, market share, market competition landscape, Porter's five forces analysis, SWOT analysis and development plans in next few years.
    To analyze the Aurora Kinase B with respect to individual growth trends, future prospects, and their contribution to the total market.
    To share detailed information about the key factors influencing the growth of the market (growth potential, opportunities, drivers, industry-specific challenges and risks).
    To project the consumption of Aurora Kinase B submarkets, with respect to key regions (along with their respective key countries).
    To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.
    To strategically profile the key players and comprehensively analyze their growth strategies.

Table of Content 

Table of Contents

Global Aurora Kinase B Market Report 2022, Forecast to 2030

1 Scope of the Study
    1.1 Aurora Kinase B Introduction
    1.2 Research Programs
    1.3 Analysis of Macroeconomic Indicators
    1.4 Years Considered
    1.5 Methodology
    1.6 Data Source
    1.7 Research Objectives

2 Aurora Kinase B Industry Overview
    2.1 Global Aurora Kinase B Market Size (Million USD) Comparison by Regions (2022-2030)
        2.1.1 Aurora Kinase B Global Import Market Analysis
        2.1.2 Aurora Kinase B Global Export Market Analysis
        2.1.3 Aurora Kinase B Global Main Region Market Analysis
    2.2 Market Analysis by Type
        2.2.1 AZD-2811
        2.2.2 CS-2164
        2.2.3 Danusertib
        2.2.4 Ilorasertib
        2.2.5 NMI-900
        2.2.6 Others
    2.3 Market Analysis by Application
        2.3.1 Anaplastic Large Cell Lymphoma
        2.3.2 Kidney Cancer
        2.3.3 Lung Cancer
        2.3.4 Prostate Cancer
        2.3.5 Others
    2.4 Global Aurora Kinase B Revenue, Sales and Market Share by Manufacturer
        2.4.1 Global Aurora Kinase B Sales and Market Share by Manufacturer (2018-2021)
        2.4.2 Global Aurora Kinase B Revenue and Market Share by Manufacturer (2018-2021)
        2.4.3 Global Aurora Kinase B Industry Concentration Ratio (CR5 and HHI)
        2.4.4 Top 5 Aurora Kinase B Manufacturer Market Share
        2.4.5 Top 10 Aurora Kinase B Manufacturer Market Share
        2.4.6 Date of Key Manufacturers Enter into Aurora Kinase B Market
        2.4.7 Key Manufacturers Aurora Kinase B Product Offered
        2.4.8 Mergers & Acquisitions Planning
    2.5 Aurora Kinase B Historical Development Overview
    2.6 Market Dynamics
        2.6.1 Market Opportunities
        2.6.2 Market Risk
        2.6.3 Market Driving Force
        2.6.4 Porter's Five Forces Analysis
    2.7 Coronavirus Disease 2019 (Covid-19): Aurora Kinase B Industry Impact
        2.7.1 How the Covid-19 is Affecting the Aurora Kinase B Industry
        2.7.2 Aurora Kinase B Business Impact Assessment - Covid-19
        2.7.3 Market Trends and Aurora Kinase B Potential Opportunities in the COVID-19 Landscape
        2.7.4 Measures / Proposal against Covid-19

3 Upstream and Downstream Market Analysis
    3.1 Upstream Analysis
        3.1.1 Macro Analysis of Upstream Markets
        3.1.2 Key Players in Upstream Markets
        3.1.3 Upstream Market Trend Analysis
        3.1.4 Aurora Kinase B Manufacturing Cost Analysis
    3.2 Downstream Market Analysis
        3.2.1 Macro Analysis of Down Markets
        3.2.2 Key Players in Down Markets
        3.2.3 Downstream Market Trend Analysis
        3.2.4 Sales Channel, Distributors, Traders and Dealers

4 Global Aurora Kinase B Market Size Categorized by Regions
    4.1 Global Aurora Kinase B Revenue, Sales and Market Share by Regions
        4.1.1 Global Aurora Kinase B Sales and Market Share by Regions (2018-2021)
        4.1.2 Global Aurora Kinase B Revenue and Market Share by Regions (2018-2021)
    4.2 Europe Aurora Kinase B Sales and Growth Rate (2018-2021)
    4.3 APAC Aurora Kinase B Sales and Growth Rate (2018-2021)
    4.4 North America Aurora Kinase B Sales and Growth Rate (2018-2021)
    4.5 South America Aurora Kinase B Sales and Growth Rate (2018-2021)
    4.6 Middle East & Africa Aurora Kinase B Sales and Growth Rate (2018-2021)

5 Europe Aurora Kinase B Market Size Categorized by Countries
    5.1 Europe Aurora Kinase B Sales, Revenue and Market Share by Countries
        5.1.1 Europe Aurora Kinase B Sales by Countries (2018-2021)
        5.1.2 Europe Aurora Kinase B Revenue by Countries (2018-2021)
        5.1.3 Germany Aurora Kinase B Sales and Growth Rate (2018-2021)
        5.1.4 UK Aurora Kinase B Sales and Growth Rate (2018-2021)
        5.1.5 France Aurora Kinase B Sales and Growth Rate (2018-2021)
        5.1.6 Russia Aurora Kinase B Sales and Growth Rate (2018-2021)
        5.1.7 Italy Aurora Kinase B Sales and Growth Rate (2018-2021)
        5.1.8 Spain Aurora Kinase B Sales and Growth Rate (2018-2021)
    5.2 Europe Aurora Kinase B Revenue (Value) by Manufacturers (2018-2021)
    5.3 Europe Aurora Kinase B Sales, Revenue and Market Share by Type (2018-2021)
        5.3.1 Europe Aurora Kinase B Sales Market Share by Type (2018-2021)
        5.3.2 Europe Aurora Kinase B Revenue and Revenue Share by Type (2018-2021)
    5.4 Europe Aurora Kinase B Sales Market Share by Application (2018-2021)

6 Asia-Pacific Aurora Kinase B Market Size Categorized by Countries
    6.1 Asia-Pacific Aurora Kinase B Sales, Revenue and Market Share by Countries
        6.1.1 Asia-Pacific Aurora Kinase B Sales by Countries (2018-2021)
        6.1.2 Asia-Pacific Aurora Kinase B Revenue by Countries (2018-2021)
        6.1.3 China Aurora Kinase B Sales and Growth Rate (2018-2021)
        6.1.4 Japan Aurora Kinase B Sales and Growth Rate (2018-2021)
        6.1.5 Korea Aurora Kinase B Sales and Growth Rate (2018-2021)
        6.1.6 India Aurora Kinase B Sales and Growth Rate (2018-2021)
        6.1.7 Southeast Asia Aurora Kinase B Sales and Growth Rate (2018-2021)
        6.1.8 Australia Aurora Kinase B Sales and Growth Rate (2018-2021)
    6.2 Asia-Pacific Aurora Kinase B Sales and Revenue (Value) by Manufacturers (2018-2021)
    6.3 Asia-Pacific Aurora Kinase B Sales, Revenue and Market Share by Type (2018-2021)
        6.3.1 Asia-Pacific Aurora Kinase B Sales Market Share by Type (2018-2021)
        6.3.2 Asia-Pacific Aurora Kinase B Revenue and Revenue Share by Type (2018-2021)
    6.4 Asia-Pacific Aurora Kinase B Sales and Market Share by Application (2018-2021)

7 North America Aurora Kinase B Market Size Categorized by Countries
    7.1 North America Aurora Kinase B Sales, Revenue and Market Share by Countries
        7.1.1 North America Aurora Kinase B Sales by Countries (2018-2021)
        7.1.2 North America Aurora Kinase B Revenue by Countries (2018-2021)
        7.1.3 United States Aurora Kinase B Sales and Growth Rate (2018-2021)
        7.1.4 Canada Aurora Kinase B Sales and Growth Rate (2018-2021)
        7.1.5 Mexico Aurora Kinase B Sales and Growth Rate (2018-2021)
    7.2 North America Aurora Kinase B Revenue (Value) by Manufacturers (2018-2021)
    7.3 North America Aurora Kinase B Sales, Revenue and Market Share by Type (2018-2021)
        7.3.1 North America Aurora Kinase B Sales Market Share by Type (2018-2021)
        7.3.2 North America Aurora Kinase B Revenue and Revenue Share by Type (2018-2021)
    7.4 North America Aurora Kinase B Sales Market Share by Application (2018-2021)

8 South America Aurora Kinase B Market Size Categorized by Countries
    8.1 South America Aurora Kinase B Sales, Revenue and Market Share by Countries
        8.1.1 South America Aurora Kinase B Sales by Countries (2018-2021)
        8.1.2 South America Aurora Kinase B Revenue by Countries (2018-2021)
        8.1.3 Brazil Aurora Kinase B Sales and Growth Rate (2018-2021)
    8.2 South America Aurora Kinase B Revenue (Value) by Manufacturers (2018-2021)
    8.3 South America Aurora Kinase B Sales, Revenue and Market Share by Type (2018-2021)
        8.3.1 South America Aurora Kinase B Sales Market Share by Type (2018-2021)
        8.3.2 South America Aurora Kinase B Revenue and Revenue Share by Type (2018-2021)
    8.4 South America Aurora Kinase B Sales Market Share by Application (2018-2021)

9 Middle East and Africa Aurora Kinase B Market Size Categorized by Countries
    9.1 Middle East and Africa Aurora Kinase B Sales, Revenue and Market Share by Countries
        9.1.1 Middle East and Africa Aurora Kinase B Sales by Countries (2018-2021)
        9.1.2 Middle East and Africa Aurora Kinase B Revenue by Countries (2018-2021)
        9.1.3 GCC Countries Aurora Kinase B Sales and Growth Rate (2018-2021)
        9.1.4 Turkey Aurora Kinase B Sales and Growth Rate (2018-2021)
        9.1.5 Egypt Aurora Kinase B Sales and Growth Rate (2018-2021)
        9.1.6 South Africa Aurora Kinase B Sales and Growth Rate (2018-2021)
    9.2 Middle East and Africa Aurora Kinase B Revenue (Value) by Manufacturers (2018-2021)
    9.3 Middle East and Africa Aurora Kinase B Sales, Revenue and Market Share by Type
        9.3.1 Middle East and Africa Aurora Kinase B Sales Market Share by Type (2018-2021)
        9.3.2 Middle East and Africa Aurora Kinase B Revenue and Revenue Share by Type (2018-2021)
    9.4 Middle East and Africa Aurora Kinase B Sales Market Share by Application (2018-2021)

10 Global Aurora Kinase B Market Segment by Type
    10.1 Global Aurora Kinase B Revenue, Sales and Market Share by Type (2018-2021)
        10.1.1 Global Aurora Kinase B Sales and Market Share by Type (2018-2021)
        10.1.2 Global Aurora Kinase B Revenue and Market Share by Type (2018-2021)
    10.2 AZD-2811 Sales Growth Rate and Price
        10.2.1 Global AZD-2811 Sales Growth Rate (2018-2021)
        10.2.2 Global AZD-2811 Price (2018-2021)
    10.3 CS-2164 Sales Growth Rate and Price
        10.3.1 Global CS-2164 Sales Growth Rate (2018-2021)
        10.3.2 Global CS-2164 Price (2018-2021)
    10.4 Danusertib Sales Growth Rate and Price
        10.4.1 Global Danusertib Sales Growth Rate (2018-2021)
        10.4.2 Global Danusertib Price (2018-2021)
    10.5 Ilorasertib Sales Growth Rate and Price
        10.5.1 Global Ilorasertib Sales Growth Rate (2018-2021)
        10.5.2 Global Ilorasertib Price (2018-2021)
    10.6 NMI-900 Sales Growth Rate and Price
        10.6.1 Global NMI-900 Sales Growth Rate (2018-2021)
        10.6.2 Global NMI-900 Price (2018-2021)
    10.7 Others Sales Growth Rate and Price
        10.7.1 Global Others Sales Growth Rate (2018-2021)
        10.7.2 Global Others Price (2018-2021)

11 Global Aurora Kinase B Market Segment by Application
    11.1 Global Aurora Kinase BSales Market Share by Application (2018-2021)
    11.2 Anaplastic Large Cell Lymphoma Sales Growth Rate (2018-2021)
    11.3 Kidney Cancer Sales Growth Rate (2018-2021)
    11.4 Lung Cancer Sales Growth Rate (2018-2021)
    11.5 Prostate Cancer Sales Growth Rate (2018-2021)
    11.6 Others Sales Growth Rate (2018-2021)

12 Market Forecast for Aurora Kinase B
    12.1 Global Aurora Kinase B Revenue, Sales and Growth Rate (2022-2030)
    12.2 Aurora Kinase B Market Forecast by Regions (2022-2030)
        12.2.1 Europe Aurora Kinase B Market Forecast (2022-2030)
        12.2.2 APAC Aurora Kinase B Market Forecast (2022-2030)
        12.2.3 North America Aurora Kinase B Market Forecast (2022-2030)
        12.2.4 South America Aurora Kinase B Market Forecast (2022-2030)
        12.2.5 Middle East & Africa Aurora Kinase B Market Forecast (2022-2030)
    12.3 Aurora Kinase B Market Forecast by Type (2022-2030)
        12.3.1 Global Aurora Kinase B Sales Forecast by Type (2022-2030)
        12.3.2 Global Aurora Kinase B Market Share Forecast by Type (2022-2030)
    12.4 Aurora Kinase B Market Forecast by Application (2022-2030)
        12.4.1 Global Aurora Kinase B Sales Forecast by Application (2022-2030)
        12.4.2 Global Aurora Kinase B Market Share Forecast by Application (2022-2030)

13 Analysis of Aurora Kinase B Industry Key Manufacturers
    13.1 AbbVie Inc
        13.1.1 Company Details
        13.1.2 Product Information
        13.1.3 AbbVie Inc Aurora Kinase B Production, Price, Cost, Gross Margin, and Revenue (2018-2021)
        13.1.4 Main Business Overview
        13.1.5 AbbVie Inc News
    13.2 Advenchen Laboratories LLC
        13.2.1 Company Details
        13.2.2 Product Information
        13.2.3 Advenchen Laboratories LLC Aurora Kinase B Production, Price, Cost, Gross Margin, and Revenue (2018-2021)
        13.2.4 Main Business Overview
        13.2.5 Advenchen Laboratories LLC News
    13.3 Aeterna Zentaris Inc
        13.3.1 Company Details
        13.3.2 Product Information
        13.3.3 Aeterna Zentaris Inc Aurora Kinase B Production, Price, Cost, Gross Margin, and Revenue (2018-2021)
        13.3.4 Main Business Overview
        13.3.5 Aeterna Zentaris Inc News
    13.4 Amgen Inc
        13.4.1 Company Details
        13.4.2 Product Information
        13.4.3 Amgen Inc Aurora Kinase B Production, Price, Cost, Gross Margin, and Revenue (2018-2021)
        13.4.4 Main Business Overview
        13.4.5 Amgen Inc News
    13.5 AstraZeneca Plc
        13.5.1 Company Details
        13.5.2 Product Information
        13.5.3 AstraZeneca Plc Aurora Kinase B Production, Price, Cost, Gross Margin, and Revenue (2018-2021)
        13.5.4 Main Business Overview
        13.5.5 AstraZeneca Plc News
    13.6 Chipscreen Biosciences Ltd
        13.6.1 Company Details
        13.6.2 Product Information
        13.6.3 Chipscreen Biosciences Ltd Aurora Kinase B Production, Price, Cost, Gross Margin, and Revenue (2018-2021)
        13.6.4 Main Business Overview
        13.6.5 Chipscreen Biosciences Ltd News
    13.7 Cielo Therapeutics Inc
        13.7.1 Company Details
        13.7.2 Product Information
        13.7.3 Cielo Therapeutics Inc Aurora Kinase B Production, Price, Cost, Gross Margin, and Revenue (2018-2021)
        13.7.4 Main Business Overview
        13.7.5 Cielo Therapeutics Inc News
    13.8 Sanofi
        13.8.1 Company Details
        13.8.2 Product Information
        13.8.3 Sanofi Aurora Kinase B Production, Price, Cost, Gross Margin, and Revenue (2018-2021)
        13.8.4 Main Business Overview
        13.8.5 Sanofi News
    13.9 Sareum Holdings Plc
        13.9.1 Company Details
        13.9.2 Product Information
        13.9.3 Sareum Holdings Plc Aurora Kinase B Production, Price, Cost, Gross Margin, and Revenue (2018-2021)
        13.9.4 Main Business Overview
        13.9.5 Sareum Holdings Plc News

14 Research Findings and Conclusion

15 Appendix

Search results for Pharmaceutical Industry

Select License Type

get a sample
Ask For Customization
Get a quote
Speak to Analyst
Buy Now

Retail

Top Rated Products